Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Expert Opinion on Investigational Drugs|February 22, 2012
Angiotensin II type 2 receptor agonists: where should they be applied?Koen Verdonk, A H Jan Danser, Joep H M van Esch
Clinical Science (London, England : 1979)|January 10, 2014
The renin-angiotensin-aldosterone system in pre-eclampsia: the delicate balance between good and badKoen Verdonk, Willy Visser, Anton H Van Den Meiracker, et al.
Therapeutic Advances in Cardiovascular Disease|January 13, 2016
The emerging role of endothelin-1 in the pathogenesis of pre-eclampsiaLangeza Saleh, Koen Verdonk, Willy Visser, et al.
International Journal of Hypertension|June 2, 2011
Long-term use of aldosterone-receptor antagonists in uncontrolled hypertension: a retrospective analysisPieter M Jansen, Koen Verdonk, Ben P Imholz, et al.
Journal of Hypertension|March 13, 2025
Risk factors for chronic hypertension 5 years after a pregnancy complicated by preeclampsia: a systematic review and meta-analysisLotte W Voskamp, Melek Rousian, Joni J Koerts, et al.
Nature Reviews. Nephrology|November 21, 2012
Key developments in renin-angiotensin-aldosterone system inhibitionBruno Sevá Pessôa, Nils van der Lubbe, Koen Verdonk, et al.
BMJ Open|November 12, 2024
FUPEC study, a prospective open-cohort on severe pre-eclampsia and cardiovascular risk factors based in the NetherlandsMarte F van der Bijl, Linda Al-Hassany, Anne I Wijtzes, et al.
Frontiers in Physiology|June 6, 2018
Mycophenolate Mofetil Attenuates DOCA-Salt Hypertension: Effects on Vascular ToneArthur D Moes, David Severs, Koen Verdonk, et al.
Pageof 4